drugset / Trial / NCT03017391

Treatment Algorithm for Nausea and Vomiting in the Palliative Phase

NCT03017391

Phase 4 Unknown 20 enrolled Radboud University Medical Center
RandomizedCrossoverOpen-labelTreatment

Summary

Nausea and vomiting are frequently occurring problems in the palliative phase of patients with cancer. Between 20-50% of them regularly suffer from nausea, retching or vomiting. Often the cause of nausea and vomiting is multifactorial and symptomatic treatment is necessary. Potential drugs for symptomatic anti-nausea therapy are metoclopramide, serotonin antagonists, the combination of both and dexamethasone as rescue medication in case of failure. There is no data that depicts which strategy is the best. This study will be conducted to unravel which treatment algorithm is most successful.

Timeline

Start
2017-01
Primary completion
2018-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Oral
Comparator Granisetron Other / unclassified 3.1 mg Topical
Comparator Metoclopramide Small molecule 10 mg Oral

Indications